Ribavirin and Zometa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ribavirin (ribavirin) and Zometa (zoledronic acid). Common drug interactions include lymphadenopathy among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Ribavirin and Zometa. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Ribavirin?

Ribavirin has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 78,532 Ribavirin users. Check the latest studies of Ribavirin.

What is Zometa?

Zometa has active ingredients of zoledronic acid. It is often used in multiple myeloma. eHealthMe is studying from 71,434 Zometa users. Check the latest studies of Zometa.

On Jul, 26, 2026

44 people who take Ribavirin and Zometa together, and have interactions are studied.

What are the common drug interactions of Ribavirin and Zometa, by gender? *:

female:

Lymphadenopathy (disease or enlargement of lymph nodes)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteonecrosis of jaw (death of bone of jaw)
Decreased appetite
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dizziness
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
Hypertension (high blood pressure)
Osteoporosis (bones weak and more likely to break)

male:

Dizziness
Dysgeusia (disorder of the sense of taste)
Diarrhoea
Hypertension (high blood pressure)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Vomiting
Abdominal pain
Alanine aminotransferase increased
Anaemia (lack of blood)
Anal pruritus (anal itching)

What are the common drug interactions of Ribavirin and Zometa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abscess oral (abscess in the mouth)
Anaemia macrocytic (a macrocytic class of anaemia)
Anxiety
Aortic dilatation
Arteriovenous fistula
Arthralgia (joint pain)
Back disorder
Back pain
Blood albumin decreased
Blood bicarbonate decreased

30-39:

n/a

40-49:

Pyrexia (fever)
Anaemia (lack of blood)
Large intestinal haemorrhage (bleeding in large intestine)
Melaena (the passage of black, tarry stools)
Pruritus (severe itching of the skin)
Rash
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
Stomatitis (inflammation of mucous membrane of mouth)
Actinomycosis (infection that causes sores, or abscesses)
Acute sinusitis

50-59:

Erythema (redness of the skin)
Erythema infectiosum (infection that results in a mild rash on the face, trunk, and limbs)
Fall
Fatigue (feeling of tiredness)
Gingival abscess (pus in gums)
Gingival ulceration (ulcer on gums)
Hypertrophic osteoarthropathy (syndrome of clubbing of the digits, periostitis of the long (tubular) bones, and arthritis)
Impaired healing
Injection site rash
Jaw disorder (jaw disease)

60+:

Anaemia (lack of blood)
Anal pruritus (anal itching)
Pneumonia
Rash pruritic (redness with itching)
Vision blurred
Weight decreased
Abdominal discomfort
Abdominal pain
Acute interstitial pneumonitis (acute revere lung disease)
Cerebral haemorrhage (bleeding within the brain)

What are the existing conditions these people have? *

High Blood Pressure: 9 people, 20.45%
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 5 people, 11.36%
Pain: 5 people, 11.36%
Nausea (feeling of having an urge to vomit): 4 people, 9.09%
Hypokalemia (low potassium): 3 people, 6.82%
Back Pain: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Ribavirin and Zometa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously